Naturhouse Health, S.A. (BME: NTH)
1.740
-0.065 (-3.60%)
Sep 4, 2024, 10:46 AM CET
Naturhouse Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 532.86 | 532.86 | 513.65 | 242.99 | 241.66 | 284.44 | Upgrade
|
Other Revenue | 1.87 | 1.87 | 1.95 | 1.96 | 0.67 | 1.17 | Upgrade
|
Revenue | 534.72 | 534.72 | 515.61 | 244.96 | 242.33 | 285.61 | Upgrade
|
Revenue Growth (YoY) | 3.71% | 3.71% | 110.49% | 1.08% | -15.15% | -16.75% | Upgrade
|
Cost of Revenue | 176.22 | 176.22 | 183.33 | 105.01 | 120.39 | 134.72 | Upgrade
|
Gross Profit | 358.51 | 358.51 | 332.28 | 139.95 | 121.95 | 150.88 | Upgrade
|
Selling, General & Admin | 111.44 | 111.44 | 101.88 | 102.89 | 80.33 | 89.51 | Upgrade
|
Other Operating Expenses | 140.31 | 140.31 | 165.86 | 88.51 | 57.3 | 74.45 | Upgrade
|
Operating Expenses | 268.73 | 268.73 | 283.57 | 204.46 | 160.26 | 189.07 | Upgrade
|
Operating Income | 89.78 | 89.78 | 48.71 | -64.51 | -38.31 | -38.19 | Upgrade
|
Interest Expense | -28.04 | -28.04 | -21.51 | -21.8 | -22.99 | -14.3 | Upgrade
|
Interest & Investment Income | 0.41 | 0.41 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Currency Exchange Gain (Loss) | -3.28 | -3.28 | 1.77 | 2.74 | -3.29 | 0.94 | Upgrade
|
Other Non Operating Income (Expenses) | -5.66 | -5.66 | 3.73 | -58.58 | 65.82 | 26.16 | Upgrade
|
EBT Excluding Unusual Items | 53.21 | 53.21 | 32.7 | -142.15 | 1.24 | -25.38 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | -0.02 | -0.02 | 0.44 | 0.54 | Upgrade
|
Asset Writedown | -5.46 | -5.46 | 5.27 | 77.38 | -99.6 | -4.44 | Upgrade
|
Other Unusual Items | - | - | - | - | - | 0.59 | Upgrade
|
Pretax Income | 47.75 | 47.75 | 37.95 | -64.79 | -97.91 | -28.69 | Upgrade
|
Income Tax Expense | -8.8 | -8.8 | -5.51 | -0.06 | 0.11 | 16.45 | Upgrade
|
Earnings From Continuing Operations | 56.55 | 56.55 | 43.46 | -64.73 | -98.02 | -45.14 | Upgrade
|
Net Income to Company | 56.55 | 56.55 | 43.46 | -64.73 | -98.02 | -45.14 | Upgrade
|
Minority Interest in Earnings | -0.23 | -0.23 | 0.04 | 0.05 | 0.12 | 3.66 | Upgrade
|
Net Income | 56.31 | 56.31 | 43.5 | -64.68 | -97.91 | -41.48 | Upgrade
|
Net Income to Common | 56.31 | 56.31 | 43.5 | -64.68 | -97.91 | -41.48 | Upgrade
|
Net Income Growth | 29.46% | 29.46% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 174 | 174 | 174 | 174 | 174 | 174 | Upgrade
|
Shares Outstanding (Diluted) | 174 | 174 | 174 | 174 | 174 | 174 | Upgrade
|
Shares Change (YoY) | 0.04% | 0.04% | 0.00% | 0.15% | -0.14% | -0.08% | Upgrade
|
EPS (Basic) | 0.32 | 0.32 | 0.25 | -0.37 | -0.56 | -0.24 | Upgrade
|
EPS (Diluted) | 0.32 | 0.32 | 0.25 | -0.37 | -0.56 | -0.24 | Upgrade
|
EPS Growth | 29.22% | 29.22% | - | - | - | - | Upgrade
|
Free Cash Flow | 39.74 | 39.74 | 29.33 | -43.72 | 18.5 | -15.34 | Upgrade
|
Free Cash Flow Per Share | 0.23 | 0.23 | 0.17 | -0.25 | 0.11 | -0.09 | Upgrade
|
Gross Margin | 67.04% | 67.04% | 64.44% | 57.13% | 50.32% | 52.83% | Upgrade
|
Operating Margin | 16.79% | 16.79% | 9.45% | -26.34% | -15.81% | -13.37% | Upgrade
|
Profit Margin | 10.53% | 10.53% | 8.44% | -26.40% | -40.40% | -14.52% | Upgrade
|
Free Cash Flow Margin | 7.43% | 7.43% | 5.69% | -17.85% | 7.63% | -5.37% | Upgrade
|
EBITDA | 105.6 | 105.6 | 63.21 | -53.3 | -15.68 | -17.06 | Upgrade
|
EBITDA Margin | 19.75% | 19.75% | 12.26% | -21.76% | -6.47% | -5.97% | Upgrade
|
D&A For EBITDA | 15.82 | 15.82 | 14.5 | 11.21 | 22.62 | 21.12 | Upgrade
|
EBIT | 89.78 | 89.78 | 48.71 | -64.51 | -38.31 | -38.19 | Upgrade
|
EBIT Margin | 16.79% | 16.79% | 9.45% | -26.34% | -15.81% | -13.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.